(DXCM:Consolidated Issue Listed on NASDAQ Global Select )
Andrew K. Balo
Executive Vice President of Clinical and Regulatory Affairs and Quality Systems, DexCom, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Andrew K. Balo, also known as Andy serves as Vice President of Regulatory and Clinical Affairs at Post-Hypothermia Corporation. Mr. Balo has been Executive Vice President of Clinical & Regulatory Affairs at Dexcom, Inc. since January 2015. Mr. Balo served as Senior Vice President of Clinical & Regulatory Affairs at Dexcom, Inc. since March 2008 until January 2015. He oversees all of Dexcom's clinical trials, statistical analyses, and regulatory submissions. He is ...
6340 Sequence DrivePhone: 858-200-0200
San Diego, California 92121
Board Members Memberships*There is no Board Members Memberships data available.
University of Maryland
University of California-Los Angeles
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Justin C. Dearborn||Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA|
Merge Healthcare Incorporated
|Eyal Shalom||Chief Executive Officer|
RadView Software Ltd.
|Lisa A. Hook||Chief Executive Officer, President, Director and Member of Neutrality Committee|
|Patrick J. Sullivan||Chief Executive Officer, President and Director|
|Kim D. Blickenstaff||Chief Executive Officer, President and Director|
Tandem Diabetes Care, Inc.
|$532.7K||Compensation as of Fiscal Year 2014.|